U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166081) titled 'Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects' on Sept. 03.
Brief Summary: This is a Phase 1, single-center, randomized, placebo-controlled, ascending dose study. The study will evaluate the pharmacokinetics (PK), pharmacodynamic (PD), preliminary efficacy, safety and tolerability of BGM0504 following daily oral administrations in non-diabetic overweight or obese adult subjects.
Study Start Date: Aug. 11
Study Type: INTERVENTIONAL
Condition:
Non-diabetic Overweight or Obese
Intervention:
DRUG: BGM0504
Administered orally
DRUG: B...